These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 26516108)
1. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. Geddings JE; Hisada Y; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N J Thromb Haemost; 2016 Jan; 14(1):153-66. PubMed ID: 26516108 [TBL] [Abstract][Full Text] [Related]
2. OC-04 - Tissue factor positive microvesicles activate platelets in vitro and in vivo and enhance thrombosis in mice. Hisada Y; Geddings JE; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N Thromb Res; 2016 Apr; 140 Suppl 1():S169-70. PubMed ID: 27161676 [TBL] [Abstract][Full Text] [Related]
3. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size. Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539 [TBL] [Abstract][Full Text] [Related]
5. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671 [TBL] [Abstract][Full Text] [Related]
7. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Leon C; Alex M; Klocke A; Morgenstern E; Moosbauer C; Eckly A; Spannagl M; Gachet C; Engelmann B Blood; 2004 Jan; 103(2):594-600. PubMed ID: 12969982 [TBL] [Abstract][Full Text] [Related]
8. Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model. Tarantino E; Amadio P; Squellerio I; Porro B; Sandrini L; Turnu L; Cavalca V; Tremoli E; Barbieri SS Pharmacol Res; 2016 May; 107():415-425. PubMed ID: 27063941 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268 [TBL] [Abstract][Full Text] [Related]
10. Microvesicles as risk markers for venous thrombosis. Rautou PE; Mackman N Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784 [TBL] [Abstract][Full Text] [Related]
12. Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly. Lopez-Vilchez I; Diaz-Ricart M; Galan AM; Roque M; Caballo C; Molina P; White JG; Escolar G J Cell Biochem; 2016 Feb; 117(2):448-57. PubMed ID: 26221761 [TBL] [Abstract][Full Text] [Related]
13. Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer. Kawano T; Hisada Y; Grover SP; Schug WJ; Paul DS; Bergmeier W; Mackman N Thromb Haemost; 2023 May; 123(5):501-509. PubMed ID: 36716775 [TBL] [Abstract][Full Text] [Related]
14. Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice. Mwiza JMN; Lee RH; Paul DS; Holle LA; Cooley BC; Nieswandt B; Schug WJ; Kawano T; Mackman N; Wolberg AS; Bergmeier W Blood; 2022 May; 139(21):3194-3203. PubMed ID: 35358299 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood. French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340 [TBL] [Abstract][Full Text] [Related]
16. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584 [TBL] [Abstract][Full Text] [Related]
17. Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism. Fricke A; Ullrich PV; Cimniak AFV; Becherer C; Follo M; Heinz J; Scholber J; Herget GW; Hauschild O; Wittel UA; Stark GB; Bannasch H; Braig D; Eisenhardt SU BMC Cancer; 2017 Aug; 17(1):527. PubMed ID: 28784104 [TBL] [Abstract][Full Text] [Related]
18. Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Hérault JP; Dol F; Gaich C; Bernat A; Herbert JM Thromb Haemost; 1999 Jun; 81(6):957-60. PubMed ID: 10404775 [TBL] [Abstract][Full Text] [Related]
19. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease. Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367 [TBL] [Abstract][Full Text] [Related]
20. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Geddings JE; Mackman N Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]